Genfit
GNFT
GNFT was delisted on the 19th of November, 2025.
1 hedge funds and large institutions have $30 invested in Genfit in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.09% less ownership
Funds ownership: 0.09% → 0% (-0.09%)
83% less funds holding
Funds holding: 6 → 1 (-5)
100% less capital invested
Capital invested by funds: $169K → $30 (-$169K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$76.5K |
| 2 |
SF
Summit Financial
Parsippany,
New Jersey
|
-$71.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$20.7K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$855 |
| 5 |
PS
Principal Securities
Des Moines,
Iowa
|
-$91 |
GNFT Hedge Fund Activity: Q4 2025 in Review
1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Genfit (GNFT) for Q4 2025, worth a combined $30 — down 100% from $169K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GNFT and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Morgan Stanley, exiting entirely with an estimated $76.5K sold.
- 1 institutional investor held Genfit (GNFT) as of Q4 2025, down from 6 in Q3 2025.
- Funds reported $30 of Genfit stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Genfit positions in Q4 2025 and 5 closed out, a net change of -5 holders.
- The largest Genfit seller in Q4 2025 was Morgan Stanley, an estimated $76.5K sold.
Based on aggregated 13F filings for Q4 2025.